SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽Demo🎬Demo VideoℹVision
clinical 3,284 words KG: CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD
Contents

CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (26)

Stress Granule Phase Separation Modulators
Score: 0.72Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67Nucleolar Stress Response Normalization
Score: 0.65Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54Microbial Metabolite-Mediated α-Synuclein Disaggregation
Score: 0.51
← Prevpg 2/2

Related Analyses (11)

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completedAPOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archivedDigital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archivedWhat are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed

Related Experiments (4)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40

See Also (15)

CD38 Inhibitor Therapy for Neurodegeneration
therapeutic · Pages share 7 hypothesesFLT3/FLT3L Cytokine Therapy for Neurodegeneration
therapy · Pages share 7 hypothesesTransdiagnostic Proteomic Changes in Neurodegeneration
gene · Pages share 7 hypothesesBDNF Therapy for Neurodegeneration
therapeutic · Pages share 7 hypothesesCRISPR/Cas9 Gene Therapy for Neurodegeneration
therapeutic · Pages share 7 hypotheses

Knowledge Graph (2 edges)

CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD references APOE
CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD references BDNF

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas